The causality between Type 2 diabetes and breast cancer: a bidirectional two-sample Mendelian randomization study

Future Oncol. 2024;20(18):1267-1274. doi: 10.2217/fon-2023-0708. Epub 2024 Apr 19.

Abstract

Objective: Observational studies showed that Type 2 diabetes increased the risk of breast cancer, and vice versa. However, it is uncertain whether the link is causal or just due to confounding factors. Using bidirectional Mendelian randomization analysis, we assessed the bidirectional causal relationship from a genetic level. Methods: Large genome-wide association studies yielded summary-level data for Type 2 diabetes and breast cancer. Results: Genetically predicted Type 2 diabetes presented no statistically significant association with overall breast cancer or its subtypes. Similarly, genetically predicted overall breast cancer or its subtypes had no causal effect on Type 2 diabetes. Sensitivity analyses yielded similar results. Conclusion: Our bidirectional Mendelian randomization studies revealed no causal links between Type 2 diabetes and breast cancer.

Keywords: Mendelian randomization; Type 2 diabetes; breast cancer; causal association.

Plain language summary

[Box: see text].

MeSH terms

  • Breast Neoplasms* / epidemiology
  • Breast Neoplasms* / etiology
  • Breast Neoplasms* / genetics
  • Causality
  • Diabetes Mellitus, Type 2* / epidemiology
  • Diabetes Mellitus, Type 2* / genetics
  • Female
  • Genetic Predisposition to Disease*
  • Genome-Wide Association Study*
  • Humans
  • Mendelian Randomization Analysis*
  • Polymorphism, Single Nucleotide*
  • Risk Factors